VENUS REMEDIES
|
The Current P/S Ratio of VENUS REMEDIES is 0.65.
Share Price | ₹297.2 | Nov 26,2024 |
Market Cap | ₹398.2 Cr | |
Sales-TTM | ₹614.6 Cr | TTM-Consolidated Results |
Price/Sales | 0.65x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of VENUS REMEDIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹398.2 Cr] as on Nov 26,2024
(/) Sales [ ₹614.6 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 0.65x ]
Thus, for VENUS REMEDIES , the investors are currently willing to pay '0.65 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of VENUS REMEDIES !
The chart below summarizes the trend in P/S Ratio of VENUS REMEDIES over the last five years.
Historical PS (Price/Sales) ratio chart of VENUS REMEDIES
PS Ratio Performance Analysis for VENUS REMEDIES
- VENUS REMEDIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.48x.
- VENUS REMEDIES 's operated at median p/e ratio of 0.6x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, VENUS REMEDIES 's p/e ratio peaked in Mar2024 at 0.73x.
- VENUS REMEDIES 's p/e ratio hit its five-year low in Mar2020 of 0.08x.
How does VENUS REMEDIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
VENUS REMEDIES | 614.6 | 0.65 | 398.2 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 50,307.7 | 8.39 | 422,271.0 |
CIPLA LTD | 26,512.0 | 4.55 | 120,605.0 |
DR REDDYS LABORATORIES LTD | 30,084.9 | 3.35 | 100,869.0 |
ZYDUS LIFESCIENCES LTD | 21,483.5 | 4.46 | 95,808.6 |
DIVIS LABORATORIES LTD | 8,614.0 | 18.71 | 161,183.0 |
MANKIND PHARMA LTD | 11,018.0 | 9.40 | 103,515.0 |
TORRENT PHARMACEUTICALS LTD | 11,225.0 | 9.73 | 109,208.0 |
LUPIN LTD | 21,431.3 | 4.33 | 92,865.9 |
AUROBINDO PHARMA LTD | 30,295.0 | 2.36 | 71,389.2 |
ABBOTT INDIA LTD | 6,066.1 | 9.65 | 58,551.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs VENUS REMEDIES 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 0.65x |
Max industry PS | 18.71x |
Median industry PS | 4.55x |
Average industry PS | 6.87x |
You may also like the below Video Courses